IL276786A - Compounds and compositions for the treatment of muscular disorders and bone disorders - Google Patents
Compounds and compositions for the treatment of muscular disorders and bone disordersInfo
- Publication number
- IL276786A IL276786A IL276786A IL27678620A IL276786A IL 276786 A IL276786 A IL 276786A IL 276786 A IL276786 A IL 276786A IL 27678620 A IL27678620 A IL 27678620A IL 276786 A IL276786 A IL 276786A
- Authority
- IL
- Israel
- Prior art keywords
- disorders
- compositions
- compounds
- treatment
- muscular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/900,533 US20180193306A1 (en) | 2012-03-23 | 2018-02-20 | Compounds and compositions for the treatment of muscular disorders and bone disorders |
| PCT/US2019/018730 WO2019164914A1 (fr) | 2018-02-20 | 2019-02-20 | Composés et compositions pour le traitement de troubles musculaires |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL276786A true IL276786A (en) | 2020-10-29 |
Family
ID=67687368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL276786A IL276786A (en) | 2018-02-20 | 2020-08-18 | Compounds and compositions for the treatment of muscular disorders and bone disorders |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3755319A4 (fr) |
| JP (1) | JP2021514380A (fr) |
| CN (1) | CN111989098A (fr) |
| AU (1) | AU2019224003A1 (fr) |
| BR (1) | BR112020016923A2 (fr) |
| CA (1) | CA3091892A1 (fr) |
| IL (1) | IL276786A (fr) |
| WO (1) | WO2019164914A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10052316B2 (en) | 2011-06-06 | 2018-08-21 | Cardero Therapeutics, Inc. | Methods and compositions for treatment of mitochondrial toxicity |
| US10898465B2 (en) | 2016-06-21 | 2021-01-26 | Epirium Bio Inc. | Utility of (+) epicatechin and their analogs |
| US11918570B2 (en) | 2020-04-13 | 2024-03-05 | The Research Foundation For The State University Of New York | Method of treatment for prevention of glucocorticoid toxicity and/or enhancement of muscle regeneration via neutrophil elastase inhibition |
| WO2024036225A1 (fr) * | 2022-08-10 | 2024-02-15 | Epirium Bio Inc. | Épicatéchine pour l'inhibition de la toxicité du glutamate |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL374966A1 (en) * | 2002-02-21 | 2005-11-14 | Wyeth | Follistatin domain containing proteins |
| JP2004161669A (ja) * | 2002-11-13 | 2004-06-10 | Ito En Ltd | 骨形成促進剤 |
| CN100361655C (zh) * | 2005-09-05 | 2008-01-16 | 中山大学 | (-)-表没食子儿茶素没食子酸酯-钙络合物固体分散体及其制备方法与应用 |
| WO2008155397A2 (fr) * | 2007-06-20 | 2008-12-24 | Galapagos N.V. | Cibles et composés moléculaires utiles dans le traitement de maladies dégénératives des os et des articulations, et procédés pour les identifier |
| KR101760758B1 (ko) * | 2008-05-14 | 2017-07-24 | 애그리컬쳐 빅토리아 서비스 피티와이 엘티디 | 질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용 |
| JP2010095474A (ja) * | 2008-10-17 | 2010-04-30 | Ito En Ltd | カルシウム吸収促進組成物及びカルシウム吸収促進飲食物 |
| KR101096574B1 (ko) * | 2008-12-12 | 2011-12-20 | 에이치 엘 지노믹스(주) | 유럽종 포도의 씨 추출물을 함유하는 골다공증 예방 또는 치료용 약학 조성물 |
| JP2011006355A (ja) * | 2009-06-25 | 2011-01-13 | Ito En Ltd | 骨密度改善組成物及び飲食物 |
| JP2013051920A (ja) * | 2011-09-05 | 2013-03-21 | Ishikawa Prefectural Public Univ Corp | 骨密度強化補助食品 |
| EP3884937A1 (fr) * | 2012-03-23 | 2021-09-29 | Cardero Therapeutics, Inc. | Composés et compositions pour le traitement d'affections musculaires |
| BR112015007131A2 (pt) * | 2012-10-04 | 2017-07-04 | Abbott Lab | métodos para melhorar o efeito de egcg em atenuar a perda muscular esquelética |
| NZ727164A (en) * | 2014-06-16 | 2018-05-25 | Unigen Inc | Compositions and methods for managing or improving bone disorders, cartilage disorders, or both |
-
2019
- 2019-02-20 CN CN201980026811.XA patent/CN111989098A/zh active Pending
- 2019-02-20 BR BR112020016923-4A patent/BR112020016923A2/pt not_active Application Discontinuation
- 2019-02-20 WO PCT/US2019/018730 patent/WO2019164914A1/fr unknown
- 2019-02-20 JP JP2020544632A patent/JP2021514380A/ja active Pending
- 2019-02-20 EP EP19756654.0A patent/EP3755319A4/fr not_active Withdrawn
- 2019-02-20 AU AU2019224003A patent/AU2019224003A1/en active Pending
- 2019-02-20 CA CA3091892A patent/CA3091892A1/fr active Pending
-
2020
- 2020-08-18 IL IL276786A patent/IL276786A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019164914A1 (fr) | 2019-08-29 |
| CN111989098A (zh) | 2020-11-24 |
| BR112020016923A2 (pt) | 2020-12-15 |
| EP3755319A1 (fr) | 2020-12-30 |
| AU2019224003A1 (en) | 2020-10-08 |
| JP2021514380A (ja) | 2021-06-10 |
| CA3091892A1 (fr) | 2019-08-29 |
| EP3755319A4 (fr) | 2021-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285782A (en) | Compounds, compositions, and methods for treating disease | |
| IL276786A (en) | Compounds and compositions for the treatment of muscular disorders and bone disorders | |
| ZA202007055B (en) | Compositions for the treatment of skin conditions | |
| SG11202011296VA (en) | Compositions and methods for the treatment of parkinson's disease | |
| ZA202006610B (en) | Compositions for the treatment of skin conditions | |
| IL284414A (en) | Methods and preparations for the treatment of Fabry disease | |
| IL276482A (en) | Compounds for pain management | |
| ZA202006234B (en) | Compositions and methods for the treatment of neurological diseases | |
| IL287280A (en) | Compounds and methods for the treatment of ocular disorders | |
| IL287796A (en) | Preparations and methods for the treatment of diseases mediated by ATPase | |
| IL279634A (en) | Preparations and methods for the treatment and prevention of neurological disorders | |
| IL287264A (en) | Compounds and methods for the treatment of ocular disorders | |
| RS65256B1 (sr) | Upotreba nmn za prevenciju i/ili lečenje bola i odgovarajuće kompozicije | |
| IL272097A (en) | Compounds for the prevention and treatment of medical disorders and their uses | |
| IL270927B (en) | fused 5,6 bicyclic compounds and compounds for the treatment of parasitic diseases | |
| IL269400A (en) | Medicines and preparations for the treatment of eye disorders | |
| ZA202101489B (en) | Compositions and methods for the treatment of parkinson's disease | |
| ZA202007320B (en) | Compounds for pain treatment, compositions comprising same, and methods of using same | |
| EP4010347A4 (fr) | Compositions et méthodes de traitement de la douleur et de troubles de la dépendance | |
| EP3856147A4 (fr) | Méthodes et compositions probiotiques destinées au traitement de lésions osseuses | |
| IL292186A (en) | Preparations and methods for treating blood disorders | |
| IL276228A (en) | Compounds and preparations for the treatment of pain | |
| IL288234A (en) | Compounds for the treatment of neuromuscular disorders | |
| GB202103887D0 (en) | Compounds for the treatment of bone disorders | |
| IL289734A (en) | Preparations and methods for the treatment of Sanfilippo disease and other disorders |